Loading...
Loading...
Poniard Pharmaceuticals, Inc.
PARD today reported financial results for the fourth quarter.
The Company reported a net loss of $5.2 million ($0.11 diluted loss per share on a loss applicable to common shares of $5.2 million) for the quarter ended December 31, 2010, compared with a net loss of $13.2 million ($0.36 diluted loss per share on a loss applicable to common shares of $13.3 million) for the quarter ended December 31, 2009.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in